Safety evaluation of combined PD-1+CTLA4 inhibition concurrently to Chemoradiotherapy (CRT) in localized Muscle Invasive Bladder Carcinoma (MIBC)
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI